In patients with AAA, the anti-inflammatory properties of simvastatin treatment were shown by reduced TNF-α as well as cyclosporine A levels and a decreased amount of phosphorylated extracellular-signal regulated kinases (ERK) 1/2 [264,265]. This evidence concerns the gene TNF and triple-A syndrome.